메뉴 건너뛰기




Volumn 23, Issue 28, 2005, Pages 6826-6828

Just when you thought the fluorouracil debate was over: S-1 and gastric cancer

Author keywords

[No Author keywords available]

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CAPECITABINE; CISPLATIN; DOCETAXEL; EPIRUBICIN; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXONATE POTASSIUM; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; TEGAFUR; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; OXONIC ACID; PYRIDINE DERIVATIVE; S 1 (COMBINATION);

EID: 27244453577     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.06.006     Document Type: Editorial
Times cited : (5)

References (16)
  • 1
    • 0032533670 scopus 로고    scopus 로고
    • Changing patterns in the incidence of esophageal and gastric carcinoma in the United States
    • Devesa SS, Blot WJ, Fraumeni JF: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83:2049-2053, 1998
    • (1998) Cancer , vol.83 , pp. 2049-2053
    • Devesa, S.S.1    Blot, W.J.2    Fraumeni, J.F.3
  • 2
    • 0141506127 scopus 로고    scopus 로고
    • Population attributable risks of esophageal and gastric cancers
    • Engel LS, Chow WH, Vaughan TL, et al: Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 95:1404-1413, 2003
    • (2003) J Natl Cancer Inst , vol.95 , pp. 1404-1413
    • Engel, L.S.1    Chow, W.H.2    Vaughan, T.L.3
  • 3
    • 0035818048 scopus 로고    scopus 로고
    • Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction
    • Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-734, 2001
    • (2001) N Engl J Med , vol.345 , pp. 725-734
    • Macdonald, J.S.1    Smalley, S.R.2    Benedetti, J.3
  • 4
    • 25844528892 scopus 로고    scopus 로고
    • Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of randomized, controlled trial
    • abstr 4001
    • Cunningham D, Allum W, Stenning SP, et al: Perioperative chemotherapy in operable gastric and lower oesophageal cancer: Final results of randomized, controlled trial. J Clin Oncol 23:308, 2005 (abstr 4001)
    • (2005) J Clin Oncol , vol.23 , pp. 308
    • Cunningham, D.1    Allum, W.2    Stenning, S.P.3
  • 5
    • 27244440600 scopus 로고    scopus 로고
    • Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma
    • Ajani J, Faust J, Ikeda K, et al: Phase I pharmacokinetic study of S-1 plus cisplatin in patients with advanced gastric carcinoma. J Clin Oncol 23:6957-6965, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 6957-6965
    • Ajani, J.1    Faust, J.2    Ikeda, K.3
  • 6
    • 1842569206 scopus 로고    scopus 로고
    • A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
    • Goldberg RM, Sargent DJ, Morton RF, et al: A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 22:23-30, 2004
    • (2004) J Clin Oncol , vol.22 , pp. 23-30
    • Goldberg, R.M.1    Sargent, D.J.2    Morton, R.F.3
  • 7
    • 0035871538 scopus 로고    scopus 로고
    • Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. Amer Soc
    • Hoff PM, Ansari R, Batist G, et al: Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: Results of a randomized phase III study. Amer Soc Clin Oncol 19:2282-2292, 2001
    • (2001) Clin Oncol , vol.19 , pp. 2282-2292
    • Hoff, P.M.1    Ansari, R.2    Batist, G.3
  • 8
    • 0033909505 scopus 로고    scopus 로고
    • Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
    • Vanhoefer U, Rougier P, Wilke H, et al: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18:2648-2657, 2000
    • (2000) J Clin Oncol , vol.18 , pp. 2648-2657
    • Vanhoefer, U.1    Rougier, P.2    Wilke, H.3
  • 9
    • 21644445993 scopus 로고    scopus 로고
    • Final results of randomized controlled phase III trial (TAX 325) comparing docetaxel combined with cisplatin and 5-fluorouracil to CF in patients with metastatic gastric adenocarcinoma
    • abstr 4002, 308s
    • Moiseyenko VM, Ajani J, Tjulandin SA, et al: Final results of randomized controlled phase III trial (TAX 325) comparing docetaxel combined with cisplatin and 5-fluorouracil to CF in patients with metastatic gastric adenocarcinoma. J Clin Oncol 23:308s, 2005 (abstr 4002)
    • (2005) J Clin Oncol , vol.23
    • Moiseyenko, V.M.1    Ajani, J.2    Tjulandin, S.A.3
  • 10
    • 32944474464 scopus 로고    scopus 로고
    • Randomized phase 3 trial of irinotecan + 5FU/folinic acid vs CDDP + 5FU in first line advanced gastric cancer patients
    • abstr 4003, 308s
    • Dank M, Zaluski J, Barone C, et al: Randomized phase 3 trial of irinotecan + 5FU/folinic acid vs CDDP + 5FU in first line advanced gastric cancer patients. J Clin Oncol 23:308s, 2005 (abstr 4003)
    • (2005) J Clin Oncol , vol.23
    • Dank, M.1    Zaluski, J.2    Barone, C.3
  • 11
    • 84871466192 scopus 로고    scopus 로고
    • Fluorouracil, leucovorin and oxaliplatin versus fluorouracil, leucovorin and cisplatin as first line therapy for patients with advanced gastric cancer
    • abstr 4015, 311s
    • Al-Batran SE, Stohlmacher J, Probst S, et al: Fluorouracil, leucovorin and oxaliplatin versus fluorouracil, leucovorin and cisplatin as first line therapy for patients with advanced gastric cancer. J Clin Oncol 23:311s, 2005 (abstr 4015)
    • (2005) J Clin Oncol , vol.23
    • Al-Batran, S.E.1    Stohlmacher, J.2    Probst, S.3
  • 12
    • 20044393181 scopus 로고    scopus 로고
    • Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: A randomized phase II study
    • Thuss-Patience PC, Kretzschmar A, Repp M, et al: Docetaxel and continuous-infusion fluorouracil versus epirubicin, cisplatin, and fluorouracil for advanced gastric adenocarcinoma: A randomized phase II study. J Clin Oncol 23:494-501, 2005
    • (2005) J Clin Oncol , vol.23 , pp. 494-501
    • Thuss-Patience, P.C.1    Kretzschmar, A.2    Repp, M.3
  • 13
    • 0037090686 scopus 로고    scopus 로고
    • Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer
    • Ross P, Nicolson M, Cunningham D, et al: Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 20:1996-2004, 2002
    • (2002) J Clin Oncol , vol.20 , pp. 1996-2004
    • Ross, P.1    Nicolson, M.2    Cunningham, D.3
  • 14
    • 0032189218 scopus 로고    scopus 로고
    • Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 in advanced gastric cancer
    • Sakata Y, Ohtsu A, Horikoshi N, et al: Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 in advanced gastric cancer. Eur J Cancer 34:1715-1720, 1998
    • (1998) Eur J Cancer , vol.34 , pp. 1715-1720
    • Sakata, Y.1    Ohtsu, A.2    Horikoshi, N.3
  • 15
    • 0842330394 scopus 로고    scopus 로고
    • Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer
    • Koizumi W, Tanabe S, Saigenji K, et al: Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer. Br J Cancer 89:2207-2212, 2003
    • (2003) Br J Cancer , vol.89 , pp. 2207-2212
    • Koizumi, W.1    Tanabe, S.2    Saigenji, K.3
  • 16
    • 0242330299 scopus 로고    scopus 로고
    • Comparison of pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients
    • Comets E, Ikeda K, Hoff P, et al: Comparison of pharmacokinetics of S-1, an oral anticancer agent, in Western and Japanese patients. J Pharmacokinet Pharmacodyn 30:257-283, 2003
    • (2003) J Pharmacokinet Pharmacodyn , vol.30 , pp. 257-283
    • Comets, E.1    Ikeda, K.2    Hoff, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.